PATENT CLAIM ANALYSIS

Application Number: 15753976
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "04400R"]

Abstract:
The invention relates to a nucleic acid molecule for use in a method of treatment of cancer. The nucleic acid molecule comprises a sequence selected from SEQ ID NO 001 to SEQ ID NO 038. The nucleic acid molecules provided are not provided for the treatment of laryngeal cancer.

Claim (Index 6):
The pharmaceutical composition for use in a method of treatment of cancer according to any one of  claims 4  and  5  additionally comprising polyethylene glycol coupled liposomes, tissue specific antibodies or virus-like particles, cell-penetrating peptides (CPP), penetrating metal particles, magnetic particles, photo activated penetrating particles, chemically activated penetrating particles and enzymatically activated penetrating particle.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 88.0
- Lexical Diversity: 1.67742
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13260904', '14472987', '15880032', '13919417', '13603300']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7741090605067815
- 35 USC 102 Novelty (BERT): 0.5154697325411836
- Combined Prediction Score: 0.7482451277102218
- Mean Citation Score: 283.457354
- Max Citation Score: 295.11322
- Similarity Product: 197.15814124591355

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test